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Bony schwannoma is a rare benign tumor derived from schwann cells of nerve fibers in the bone. It accounts for
less than 1% of bony benign tumor, and prone to occur in the sacrum and mandible, occurrence in scapula is very
rare. Here we report a 42-year-old woman with the chief complaint of pain in the left scapula. Imaging examination
showed a giant, irregular, swelling lesion with distinct border involving the left scapula, extending into the left
shoulder glenoid and pressing the surrounding soft tissues. Needle biopsy showed that the tumor was composed
of spindle cells with S-100 protein positive, mimicking a benign neurogenic tumor. Then a complete excision was
performed by removing the tumor and the surrounding tissues including partial left shoulder glenoid. Histologically,
Antoni type A areas were the predominant microscopic pattern with occasional alternation by Antoni type B areas.
Immunohistochemistry found that the neoplastic cells were scatteredly positive for S-100 protein. All these features
suggest a diagnosis of an intraosseous schwannoma of the left scapula. Follow-up of the patient for ten months
found no recurrence or sign of other tumors following complete tumor resection without any adjuvant therapy. In
conclusion, this case of giant intraosseous schwannoma of the scapula is a rare benign bony tumor, and its
diagnosis combined with clinical, imaging and pre-operative needle biopsy is important to guide further therapy,
and avoid overtreatment.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1399352761104042
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Schwannomas (neurilemomas) are benign neurogenic
tumors arising from Schwann cells of the peripheral
nerves and spinal nerve roots. These tumors have a pre-
dilection for the head and neck, the extremities and the
posterior mediastinum [1,2]. Schwannoma of the bone is
a rare benign tumor accounting for less than 1% of bony
benign tumor [3]. Intraosseous schwannoma occurring
in sacrum and mandible is higher than in other places
[4,5], including the long bones, vertebra, fibula and
frontal bone [3,6-8]. Here we report a case of rare giant
scapular schwannoma through imaging, morphological
and immunohistochemical studies. A ten-month follow-
up after the tumor resection without any other adjuvant
therapy showed no recurrence or sign of other tumors.* Correspondence: lyzhang1@126.com
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A 42-year-old female presented to our hospital with left
shoulder pain for more than 4 years. The pain usually
occurs in the early morning or after exertion, with no
obvious effect to physiotherapy. The pain became more
severe two weeks ago. There was no trauma history of
scapula and she was otherwise healthy.
Percussion tenderness was elicited on the left shoulder
region on physical examination. Laboratory tests re-
vealed no obvious abnormality. Conventional chest X-
ray showed an oval low-density region in the left scapula
with relatively clear border (Figure 1a). Computerized
tomography (CT) conducted in local hospital showed a
destruction of the left glenoid and a huge mass in the
left scapula. The mass extends into the surrounding soft
tissues including the supraspinatus fossa, infraspinatus
fossa and subscapularis gap. In addition, magnetic reson-
ance imaging (MRI) identified a solitary irregular lobular
mass measuring about 88 × 80 × 40 mm in the left. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Imaging inspection. a Conventional chest X-ray views of an oval mass in the left scapula, with clearer boundary and surrounded by a
thin layer of harden zone. b, c and d MRI shows a solitary irregular lobular soft tissue mass measuring about 88 × 80 × 40 mm in the left scapula,
the boundary was clear, which showed low intensity signal in T1WI (1b) and high intensity signal in T2WI. (1c) horizontal plane, (1d) coronal plane.
The lesion involved the glenoid and entered into surrounding soft tissues, adjacent muscles were compressed and shifted.
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clearer boundary, with low to intermediate intensity on
T1-weighted images (T1WI) (Figure 1b) and high inten-
sity on T2-weighted images (T2WI) (Figure 1c and d),
also with destruction of the left scapula and glenoid. No
obvious abnormality was found in the contralateral
scapula.
Needle biopsy showed that the tumor was composed
of spindle cells, S-100 protein was positive with immu-
nohistochemistry. Therefore, it was considered a neuro-
genic benign tumor, specifically schwannoma. Then she
received a complete left scapular tumor resection. Dur-
ing the surgery, a dark red nodular mass was seen below
the left shoulder joint. The proximal cartilage of the
glenoid was fragmented and the joint capsule was cut,
there was no effusion in the joint cavity. The nodular
mass grew in a dumbbell-shaped configuration, with one
side in the soft tissue and the other side entered into the
joint surface. There were two small nodules around the
big one, and the borders of them were also clear. The
tumor along with part of the scapula and some sur-
rounding soft tissues were surgically removed and
refilled with artificial bone cement. The gross specimen
showed a solid lobular tumor with clear boundary, partly
located within the bone. The largest nodule measured
6.0 × 5.0 × 4.5 cm, and the two smaller nodules next the
largest one measured 3.5 and 2.0 cm in diameter re-
spectively. The cut surface of the tumor was yellowish
white, smooth, solid with medium texture, local edge
was a little hard (Figure 2a).
Specimens were fixed in 10% neutral formalin, dehy-
dration, paraffin-embedded. The hard areas were cut
into sections (4 μm thick) after decalcification. HE and
immunohistochemical stains were performed. The pri-
mary antibodies included S-100, SMA, Desmin, CD117,
CD34 and Ki-67. All primary antibodies were mouseanti-human monoclonal antibodies, dilated 1:100 (Zymed
Laboratories, South San Francisco, CA). A DAB (3, 3′-dia-
mino-benzidine-tetrahydrochloride) substrate-chromogen
kit (Zymed Laboratories, South San Francisco, CA) was
used to visualize signals. All sections were counterstained
with hematoxylin.
Histopathology
Microscopic examination showed that the tumor mass
was composed of spindle cells with twisted nuclei and
the low-density areas (Antoni Type B) staggered with
high density areas (Antoni Type A). The nuclei were pal-
isading arrangement and formed the "Verocay bodies".
The morphological features of the tumor mass were
similar to that of the needle biopsy specimen (Figure 2b).
Some tumor tissues were founded in the bone (Figure 2c).
Focal areas showed bleeding and degeneration (Figure 2d).
Atypical nuclei were not obvious in most of the region,
but enlarged and pleomorphic nuclei could be seen in
small areas of the region. Mitotic figures could be found
occasionally (Figure 2e).
Expression of S-100 was found in some of the cytoplasm
and nuclei of the spindle neoplastic cells (Figure 2f).
SMA, Desmin and CD117 were all negative. CD34 was
positive only for the vascular endothelial cells. The Ki-67
proliferation index was less than 2%.
The patient did not receive any adjuvant therapy after
the tumor resection. Until the time of writing, she had
been followed up for 10 months after the tumor resec-
tion, no sign of recurrence or other tumor was noticed.
Discussion
Schwannoma is a benign tumor originating in schwann
cells of the nerve fibers. It usually occurs in the head
and neck. Intraosseous schwannoma is rare accounting
for <1% of primary benign bone tumors [3]. Besides of
Figure 2 Gross observation, morphologic features and immunohistochemistry. a Gross specimen showed the tumor was solid, irregular
lobular, the boundary was clear, with two small nodules next the largest one, some part of the tumor connected with the bone. The cut surface
was pale yellow, with medium texture. b to e Hymatoxylin and eosin stain showed the morphologic features of the neoplastic cells. Histological
examination of the resection specimen revealed that the greatest portion of the tumour was composed of interlacing bundles of elongated cells
with spindle-shaped nuclei (2b). Some tumor tissues located in the bone (2c). Focal area accompanied with bleeding and degeneration (2d). The
nuclei were corrugated, atypia was not obvious, enlarged and pleomorphic nuclei could be seen in some region, mitotic figure could be found
occasionally (2e, black arrow). (Magnification: 2b and 2e, ×400; 2c and 2d, ×100). f Positive IHC signals were visualized with brown yellow color.
Cytoplasmic and nuclear immunostaining of neoplastic cells with S-100 protein (Magnification, ×400).
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nnoma also occurrs in the long bones, vertebra, fibula and
frontal bone, etc. The symptoms are mild, and the tumor
is usually symptom free until the tumor becomes larger
with visible pain and/or swelling. X-ray usually shows a
benign bone tumor mass. MRI is particularly helpful in
pre-operative diagnosis as it shows the internal texture
characteristics of the encapsulated mass. But this method
is not applicable to all schwannoma.
The histopathological features of intraosseous schwan-
noma are similar to soft tissue schwannoma. The tumor
cells have spindle, fences-like arrangement cells and may
have alternating Antoni type A and B areas. The nuclei
can be pleomorphic, but mitotic figure is rare. Large
schwannomas (> 8 cm) often undergo cystic degener-
ation due to haemorrhage or necrosis [9,10]. Neither
tumor size nor mitotic figure has been found to reflect
malignant behavior [11].
In this case the patient appeared pain of left scapula for
more than four years, combined with X-ray, CT and MRI
inspections and histologically showing manifest Antoni
type A and B patterns. Most of the nuclei were moderate,
and immunohistochemically some of the neoplastic cells
were positive for S-100 protein, the Ki-67 proliferation
index was very low. The final diagnosis of giant scapular
schwannoma was made, which was consistent with the
needle biopsy results. Sometimes, the imaging appears fea-
tures of benign tumor, the histological features also show
the morphology of schwannoma, so both the imaging and
histology show benign tumor features [12]. However, al-
though with advanced imaging techniques even with fineneedle biopsy, sometimes schwannoma still will be mis-
diagnosed pre-operatively [13]. Because of the rarity of
these intraosseous schwannoma, it is important that the
diagnosis is made pre-operatively by the pathologist exam-
ining the needle biopsies and the radiologist interpreting
the scans. The diagnosis of this benign tumor may influ-
ence further treatment by limiting surgical invasiveness
and avoiding unnecessary adjuvant therapy.
Clinically it is often difficult to judge whether it is the
outside soft tissue schwannoma involving the bone or
intraosseous schwannoma involving the surrounding soft
tissues, as they have similar histopathological morphology.
Schwannomas can involve bone by three mechanisms: (1)
tumors may arise centrally within bones; (2) tumors can
arise within the nutrient canal and grow in a dumbbell-
shaped configuration, enlarging the canal, or (3) extraoss-
eous tumors can cause secondary erosion of bone [14].
On the base of imaging examination, intraoperative find-
ings of dumbbell-shaped tumor in and outside the scapu-
lar glenoid and gross examination, this case demonstrates
an example of intraosseous schwannoma.
For differential diagnosis, neurofibroma, malignant per-
ipheral nerve sheath tumor (MPNST), fibrous histiocy-
toma, and nonossifying fibroma should be distinguished.
Neurofibroma may be a manifestation of neurofibroma-
tosis type 1 (NF-1) and the probability of recurrence in
neurofibroma is higher than schwannoma [15]. Neuro-
fibroma has the potential for malignant transformation
and about 15–16% of patients with neurofibromatosis
present with malignant transformation [16]. Neurofibro-
mas lack the thick collagenous capsule of schwannomas.
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acteristics of the encapsulated mass. Neurofibromas also
lack the Antoni type A and B patterns and "Verocay
bodies" which are ususlly apparent in schwannomas.
MPNST represents 5-10% of all soft tissue sarcomas
and is often associated with NF-1 [17]. However, there
was case reported that MPNST had no relationship with
NF-1 [18]. MPNST occurs in man more than in woman
and occurrences in the skin, head and neck, mediastinal
and retroperitoneal are higher than in other places. It
was even reported in the ulna of a dog as a model to
study human [19]. MPNST usually grows rapidly. Histo-
logically, MPNST usually are comprised of infiltrative,
dense and relatively uniform spindle or oval neoplastic
cells. Pleomorphic and atypical neoplastic cells are obvi-
ous, and mitotic figure and necrosis could be found easily.
The Ki-67 proliferation index in MPNST is much higher
than in benign schwannoma. Fibrous histiocytoma usually
is composed of spindle cells, multinucleated osteoclast-
like giant cells, foamy cells and chronic inflammatory cells,
often along with interstitial hemorrhage and hemosiderin.
Pelvis, especially the ilium, is the most common site of fi-
brous histiocytoma. It also occurs in the backbone of tibia
and fibula, but it requires a combination of clinical,
radiological examnation to exclude other bone tumors
such as giant cell tumor of bone, nonossifying fibroma,
etc. to make a fibrous histiocytoma diagnosis. Nonossi-
fying fibroma often occurs in young people less than
20 years-old, clinically with less pain. It usually occurs
in the metaphyseal of long bone. Radiographically it has
bubble-type sclerosis edge. The diagnosis of nonossify-
ing fibroma mainly relies on clinical symptoms and im-
aging which is similar to that of fibrous histiocytoma.
Almost all the intraosseous schwannomas behave in a
benign manner, similar to extraosseous soft tissue schwan-
nomas. Primary schwannomas of the bone can be success-
fully treated by local complete excision alone [3]. Some
schwannomas would malignant change [20,21] and man-
dibular malignant schwannoma has been reported [22].
Through imaging, morphology and immunohistochemis-
try, we diagnosed that this case is a rare giant benign
intraosseus schwannoma occurring in the scapula. In view
of the huge tumor size, accompanied with hemorrhage
and degeneration, focal areas appeared pleomorphic, atyp-
ical and mitotic neoplatic cells, low malignant potential
could not be completely ruled out, although the follow-up
showed no reccurrence or sign of other tumors in the pa-
tient for 10 months after complete tumor resection. It
needs a long-term follow-up to observe the biological be-
havior of this intraosseous schwannoma.
Conclusion
In conclusion, we report here a rare case of giant intra-
osseous schwannoma in the left scapula on the basis ofimaging, histopathological pattern and immunohisto-
chemical expression of S-100 protein. The histological
features of this tumour suggest that this intraosseous
schwannoma was a benign tumor. The use of immuno-
histochemistry may be helpful in distinguishing this
type of neoplasm from other spindle cell tumors with
similar morphology. Finally, the diagnosis was made
pre-operatively from clinical and radiological findings,
and needle biopsy results, that was beneficial to the pa-
tient for avoiding unnecessary adjuvant therapy.
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